As a leader in translational research, our insights into gene therapy, recombinant DNA technology, cancer biology and other fields are responsible for bringing the world greater understanding of cancer, HIV/AIDS and other life-threatening diseases.
City of Hope is one of only 45 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and education.
To facilitate scientific progress, City of Hope provides investigators and their laboratory teams access to sophisticated support services and state-of-the-art equipment.
The Office of Technology Licensing works closely with City of Hope inventors to identify, protect, and create effective strategies to commercially advance their inventions and technologies.
The Irell & Manella Graduate School of Biological Sciences trains students in a collaborative and diverse environment to apply their talents and creativity to advance understanding in seeking the cures for diseases.
Jeff Andrews and his wife Heidi were married only three years and raising a two-year-old son when Jeff was diagnosed with cancer, an experience that brought unexpected challenges to their relationship. Now, a year later, the couple has learned new coping strategies through Couples Coping with Cancer Together, a support group sponsored by City of Hope’s Department of Supportive Care Medicine.
When she was just 9 years old, Gina Marchini had to be airlifted to a hospital when her undiagnosed diabetes nearly killed her. This week, the 33-year-old kindergarten teacher from Palmer, Alaska told a national television audience that, after an islet cell transplant performed at City of Hope last year, her body is now producing its own insulin.
Neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., associate professor in the Division of Neurosurgery, at City of Hope, shares what cancer patients can takeaway from President Carter’s cancer journey.
City of Hope researchers have announced game-changing technology to chemically modify antibodies (Abs) so that they can cross cell membranes to disable disease-causing proteins inside cells, a feat long-sought by researchers worldwide. The new technology is expected to lead to never-before-imagined targeted treatments for some of the most intractable diseases.
Grieving for the people we love after they die is a behavior as innate and natural as loving them in life. And while grief is a universal experience, it’s never easy to deal with—especially when a loved one passes after an emotional battle with cancer.
Dept Surgery ~ Nero-Oncology Tumor Board February 12, 2016
Dept of Surgery: Title - Head and Neck Tumor Board February 12, 2016
Topics in Cancer Genetics Research February 12, 2016
Dept of Surgery ~ Pre-Operative Conference February 15, 2016